Recombinant Mouse Excitatory amino acid transporter 2(Slc1a2),partial

Code CSB-EP021433MO
Size US$2466 How to order?
Image
  • (Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
  • Based on the SEQUEST from database of E.coli host and target protein, the LC-MS/MS Analysis result of CSB-EP021433MO could indicate that this peptide derived from E.coli-expressed Mus musculus (Mouse) Slc1a2.
  • Based on the SEQUEST from database of E.coli host and target protein, the LC-MS/MS Analysis result of CSB-EP021433MO could indicate that this peptide derived from E.coli-expressed Mus musculus (Mouse) Slc1a2.
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Purity Greater than 90% as determined by SDS-PAGE.
Target Names Slc1a2
Uniprot No. P43006
Alternative Names Slc1a2; Eaat2; Glt1Excitatory amino acid transporter 2; GLT-1; Sodium-dependent glutamate/aspartate transporter 2; Solute carrier family 1 member 2
Species Mus musculus (Mouse)
Source E.coli
Expression Region 143-238aa
Target Protein Sequence HPGNPKLKKQLGPGKKNDEVSSLDAFLDLIRNLFPENLVQACFQQIQTVTKKVLVAPPSEEANTTKAVISMLNETMNEAPEETKIVIKKGLEFKDG
Note: The complete sequence including tag sequence, target protein sequence and linker sequence could be provided upon request.
Mol. Weight 37.6kDa
Protein Length partial
Tag Info N-terminal GST-tagged
Form Liquid or Lyophilized powder
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
Buffer If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol.
Note: If you have any special requirement for the glycerol content, please remark when you place the order.
If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0.
Reconstitution We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Troubleshooting
and FAQs
Protein FAQs
Storage Condition Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Shelf Life The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Lead Time Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Notes Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Datasheet & COA Please contact us to get it.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Sodium-dependent, high-affinity amino acid transporter that mediates the uptake of L-glutamate and also L-aspartate and D-aspartate. Functions as a symporter that transports one amino acid molecule together with two or three Na(+) ions and one proton, in parallel with the counter-transport of one K(+) ion. Mediates Cl(-) flux that is not coupled to amino acid transport; this avoids the accumulation of negative charges due to aspartate and Na(+) symport. Essential for the rapid removal of released glutamate from the synaptic cleft, and for terminating the postsynaptic action of glutamate.
Gene References into Functions
  1. Selective deletion of GLT1 in the diencephalon, brainstem and spinal cord reproduces the phenotypes (excess mortality, lower body weight, and lethal spontaneous seizure) of the global GLT1 knockout mice. By contrast, dorsal forebrain-specific GLT1 knockout mice showed nonlethal spontaneous seizures at the limited period from P12 to 14 and selective neuronal death in cortical layer II/III and the hippocampus. PMID: 29214672
  2. Study shows that high-fat feeding induces metabolic disorders and disrupts lactate metabolism in the hippocampus. Glial glutamate transporters GLAST and GLT-1 may contribute to the high-fat diet induced abnormalities of the hippocampal lactate metabolism. PMID: 29051084
  3. Interaction of the IgG-AQP4 complex with FcgammaRs triggers coendocytosis of the excitatory amino acid transporter 2. PMID: 28461494
  4. GLT1 deletion in spinal cord causes motor deficits. GLT1 deletion in spinal cord induces spinal motor neuron loss. GLT1 deletion in spinal cord induces gliosis in the ventral horn. PMID: 29458024
  5. Authors demonstrated that the upregulation of GLT1 corrected Purkinje cell firing and motor incoordination in myotonic dystrophy. PMID: 28658620
  6. suggest that VGluT2 and GLT-1 may be differentially involved in the pathogenesis of amyotrophic lateral sclerosis via abnormal glutamate homeostasis at the presymptomatic stage and end stage of disease, respectively PMID: 28526579
  7. Immunoreactivity of vGluT1 in continuous theta-burst stimulation (iTBS; cTBS) repeated session (RS) decreased, while GLT-1 increased in cTBS SS and cTBS RS, compared to control PMID: 27623095
  8. Decreased glial and synaptic glutamate uptake due to low GLT-1 expression has been found in the striatum of HIV-1 gp120 transgenic mice. PMID: 26567011
  9. interactions of NF-kappaB and N-myc with GLT-1/EAAT2 promoter sequences was significantly elevated in the ipsi-lateral cortex of both adult and old Traumatic brain injury mice. PMID: 26081154
  10. infection of co-cultures with shRNA directed against recombination signal binding protein for immunoglobulin kappa J, a Notch effector, also reduces endothelia-dependent increases in enhanced green fluorescent protein and GLT-1 PMID: 28771710
  11. Mutation of the caspase-3 cleavage site in the astroglial glutamate transporter EAAT2 delays disease progression and extends lifespan in the SOD1-G93A mouse model of amyotrophic lateral sclerosis PMID: 28342750
  12. The upregulation of GLT-1 induced by transplanted neural precursor cells was found to rely on the secretion of VEGF by neural precursor cells PMID: 27733606
  13. We demonstrate that the R6/1 transgenic mouse model of HD has lower basal levels of cystine, and showed depressive-like behaviors in the forced-swim test. Administration of NAC reversed these behaviors. This effect was blocked by co-administration of the system xc(-) and GLT-1 inhibitors CPG and DHK, showing that glutamate transporter activity was required for the antidepressant effects of NAC PMID: 27179791
  14. Consistent with glutamate dysregulation, analysis of neurons reveal changes in morphology including a reduction in dendritic spines, VGlut1 and NeuN immunoreactivity PMID: 27281462
  15. A significant initial increase in dorsal hippocampal GLT1 immunoreactivity and protein levels were observed 1day post epilepsy and followed by a marked downregulation at 4 and 7days post epilepsy with a return to near control levels by 30days post epilepsy. PMID: 27155358
  16. These results demonstrate that focal restoration of GLT1 expression in the superficial dorsal horn is a promising target for treating chronic neuropathic pain following SCI. PMID: 26496514
  17. Lipid raft integrity, ensured by DHCR24, plays a crucial role in the ischemic brain by guaranteeing EAAT2-mediated uptake of glutamate excess. PMID: 26628388
  18. Findings suggest that focal restoration of glutamate transporter 1,expression in astrocytes of the cervical spinal cord using adeno-associated virus delivery is not an effective therapy for amyotrophic lateral sclerosis. PMID: 25818008
  19. we have demonstrated for the first time that DOR receptor activation induces astrocytic expression of EAAT1 and EAAT2 PMID: 25052197
  20. neuronal GLT-1 but not astrocytic GLT-1 contributed significantly to glutamate uptake. astrocytic GLT-1 performs critical functions required for normal weight gain, resistance to epilepsy, and survival. PMID: 25834045
  21. data indicate that the surface expression and function of EAAT2b can be rapidly modulated through the disruption of its interaction with DLG1 by CaMKII activation. PMID: 25834051
  22. Inhibition of L-glutamate transport reveals increases in EAAt2 cell surface expression in astrocytes. PMID: 24095695
  23. results provide evidence that disrupting glutamate transporter GLT-1 in habenular astrocytes increases neuronal excitability and depressive-like phenotypes in behaviors and sleep. PMID: 25471567
  24. Results show that a fraction of EAAT2 undergoes SUMO1 conjugation under physiological conditions; sumoylated EAAT2 localizes to intracellular compartments, whereas non-sumoylated EAAT2 resides on the plasma membrane PMID: 24753081
  25. conclude that the association between GLT-1 and mitochondria is modest, is driven by synaptic activity and dependent on polymerized actin filaments. PMID: 24814819
  26. IL-1beta treatment of AEG-1-overexpressing astrocytes significantly lowered expression of excitatory amino acid transporter 2 PMID: 24855648
  27. Study suggests that there is a remarkable subcellular heterogeneity of GLAST and GLT-1 expression in the developing hippocampus PMID: 23939750
  28. GLT1 overexpression exacerbates neuronal damage and increases respiratory impairment following cervical spinal cord injury. PMID: 24872566
  29. TBI affects expression of Kir4.1 and GLT-1 genes in age- and time dependent manner and it may lead to accumulations of more K(+) and glutamate early in the synapse of old mice as compared to adult PMID: 24026668
  30. Pharmacological enhancement of EAAT2 translation may be a therapeutic strategy for the treatment of neurodegenerative diseases. PMID: 24569372
  31. GLT-1 plays a role in glutamate homeostasis in the neocortex PMID: 24224925
  32. Proteome analysis and conditional deletion of the EAAT2 glutamate transporter provide evidence against a role of EAAT2 in pancreatic insulin secretion in mice. PMID: 24280215
  33. Unitary current amplitudes of EAAT5 anion channels turned out to be approximately twice as high as single-channel amplitudes of GLT-1c. PMID: 24307171
  34. FMRP positively regulates translational expression of mGluR5 in astroglial cells, and FMRP-dependent down-regulation of mGluR5 underlies GLT1 dysregulation in fmr1(-/-) astrocytes PMID: 23396537
  35. EAAT2 expression in astrocytes, regulated by adenosine signaling, controls ethanol drinking in mice. PMID: 23032072
  36. Astrocyte GLT1 plays a role in limiting secondary cell death following spinal cord injury; compromise of key astrocyte functions has significant effects on outcome following traumatic spinal injury. PMID: 21882244
  37. Amyloid-beta peptide Abeta1-42 markedly prolongs the extracellular lifetime of synaptically released glutamate by reducing GLT-1 surface expression in mouse astrocytes. PMID: 23516295
  38. Data indicate that direct miR-124a transfection significantly and selectively increases protein expression levels of GLT1 in cultured astrocytes. PMID: 23364798
  39. GLT-1 activation appears to play a key role in the preventive effect of beta-lactam antibiotics on cannabinoid tolerance. PMID: 21536061
  40. These findings demonstrate that GltI and Glast negatively regulate calcium-dependent proliferation in vitro and that their upregulation after injury is associated with decreased proliferation after brain trauma. PMID: 22092549
  41. Spatial and temporal alterations in GLT1 expression observed after spinal cord injury result from both astrocyte death and gene expression changes in surviving astrocytes. PMID: 21488085
  42. glutamine synthetase was coexpressed with GLT-1 in islets, which suggests that, as with liver and brain, one possible role of GLT-1 in the pancreas is to support glutamine synthesis PMID: 22114258
  43. Evidence against cellular internalization in vivo of NMO-IgG, aquaporin-4, and excitatory amino acid transporter 2 in neuromyelitis optica. PMID: 22069320
  44. This study demonistrated that in cerebral ischemia in mice down regulation the GLT-1. PMID: 21911209
  45. deficits in lgt1 function compound the effects of familial amyloid-beta protein precursor and presenilin-1 mutant transgenes in younger animals and thus may contribute to early occurring pathogenic processes associated with Alzheimer's disease PMID: 21677376
  46. These data imply a glutamate cycle in which glutamate is carried into the granules by VGLUT3 and carried out by EAAT2. PMID: 21853059
  47. GLT1 is a new player in glutamate homeostasis and signaling in the islet of Langerhans; beta-cells critically depend on its activity to control extracellular glutamate levels and cellular integrity PMID: 21335552
  48. these results suggest that A1 receptor-mediated signaling regulates EAAT2 expression in astrocytes. PMID: 21291865
  49. Early treatment with ceftriaxone prior to the onset of epilepsy increased expression of astrocyte glutamate transporters, decreased extracellular glutamate levels, neuronal death, and seizure frequency, and improved survival in Tsc1(GFAP)CKO mice. PMID: 20045054
  50. SOD1-G93A transgene and HO-1 are preferentially over-expressed in the lumbar spinal cord and GLT-1 are down-regulated. PMID: 20303959

Show More

Hide All

Subcellular Location Cell membrane; Multi-pass membrane protein.
Protein Families Dicarboxylate/amino acid:cation symporter (DAACS) (TC 2.A.23) family, SLC1A2 subfamily
Tissue Specificity Detected in brain. Detected in embryonic forebrain, especially in globus pallidus, perirhinal cortex, lateral hypothalamus, hippocampus, and on fimbria and axonal pathways connecting the neocortex, basal ganglia and thalamus (at protein level). Isoform GL
Database Links

KEGG: mmu:20511

STRING: 10090.ENSMUSP00000079100

UniGene: Mm.267547

Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
Address
7505 Fannin St. Ste 610-312, Houston, TX 77054, USA
Join Us with

Subscribe newsletter

Leave a message

© 2007-2022 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1